Pan Genome Systems’ vaccine technology is built on the discovery of proprietary genetic biomarkers and vaccine constructs. These biomarkers and constructs are unique to mycobacteria avium paratuberculosis, the bacteria that causes Johne’s Disease.

Pan Genome Systems’ proprietary biomarkers and techniques provide the targets and methods necessary to alter specific genetic characteristics of the bacteria. This allows Pan Genome Systems’ vaccines to solicit a strong and robust immune response, and sustained bacterial immunity in the host animal, while simultaneously preserving the health of the animal by eliminating bacterial virulence.

Pan Genome Systems’ technology is patent-protected and unique in the marketplace. The company’s proprietary technology platform is paving the way for a revolution in vaccines and animal healt